SVFC~~~~~~~IntelliCell BioSciences Receives US Patent for

New Post Public Reply Private Reply Replies (0) Message Board

Jun 13, 2013 at 2:18 PM

SVFC~~~~~~~IntelliCell BioSciences Receives US Patent for its Stem Cell Extraction Technology

NEW YORK, June 13, 2013 /PRNewswire via COMTEX/ -- IntelliCell BioSciences, Inc. ("Company") (SVFC) announces that it has been notified by the US Patent office that its patent for stem cell extraction technology has been published. IntelliCell's proprietary patented method for deriving blood vessel originated vascular cells from adipose (fat) tissue by use of ultrasonic cavitation has been made official. This technology involves an innovative mechanical method for the separation of stromal vascular fraction cells from adipose (fat) tissue, without the use of enzymes. Vascular cells derived by IntelliCell's proprietary method are potentially useful in bringing the promise of regenerative medicine to many therapeutic and aesthetic procedures. Investors can access the published patent at the US Patent website by entering the patent # 8,440,440. Link to patent website: http://patft.uspto.gov/netahtml/PTO/srchnum.htm
IntelliCell's Chairman and CEO, Dr. Steven Victor, stated "Our Company is very pleased to announce today that with the publishing of our patent, our technology is now protected and we expect our international patent publication in a short time."

About IntelliCell BioSciences, Inc.

IntelliCell BioSciences is a Regenerative Medicine company developing novel technologies that address the regenerative, curative and preventative conditions of disease states with high unmet clinical needs. The Company has several patent-pending applications including the patent that was recently published, an industry unique method of obtaining autologous stromal vascular fraction cells (SVF) cells from the vasculature surrounding adipose tissue containing adult stem cells and a robust population of regenerative healing cells. The Company is also pioneering the development of autologous and allogeneic cells from living and non-living tissue donors for research purposes. IntelliCell is planning a series of in-human clinical studies with top tier universities for the treatment of osteoarthritis, multiple sclerosis, lower limb ischemic wounds, and gum regeneration in the oral cavity as well as medical aesthetics. The Company has developed a first in class cGTP cellular processing facility in New York City, purpose built and designed to be fully integrated into an ambulatory surgery center.

Forward-Looking Statements

Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "will reach," "will change," "will soon," "should," "could," "would," "may," "can" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.

Contacts:Anna Rhodes, IntelliCell BioSciences, Inc. Phone: (646) 576-8710 Email: arhodes@intellicellbiosciences.com

Melissa Diaz, South Street Media, Inc. Phone: (917) 937-8968 Email: info@southstreetmedia.com

SOURCE IntelliCell BioSciences, Inc.

http://rt.prnewswire.com/rt.gif?NewsItemId=NE...d=20130613

www.prnewswire.com

Symbotic Inc. (SYM) Stock Research Links

SYM Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Revamp Preschool Questions for Richer Conversations

Preschoolers, those tiny agents of chaos, come home with stories that you'd need a magnifying glass to find. Ask 'em "How was school?" and you're met with blank stares or a one-liner. Tami Nix of Archway Academy has been at this game for over 40 years, and she's got a trick or six up her sleeve. Ditch the Generic: Get Specific Yep, those generic questions are about as...

Govee's Retro Holiday Lights: A Festive Nostalgia Trip

Ah, the holidays—they're creeping up like a kid sneaking downstairs for a peek at their gifts. But it's not the gifts under the tree that brighten a room, it's those lights draping the tree itself. Enter Govee, bringing us back to that vintage glow we all remember from our childhoods. They've teamed up with Brady Tolbert, a design whiz who can make a living room look...

Electra's Ultra Short Aircraft Revolutionizes Air Travel

From Tarmacs to Heliports: A New Era in Air Travel The aviation world doesn’t often see a sea change, but when a fixed-wing flyer touches down at a heliport, it grabs your attention. Electra’s recent leap into Manhattan’s Downtown Skyport highlights a promising shift in regional air mobility, doing away with the age-old reliance on long runways. It’s a shift that...

Pacsun Finds Gear: 177% Sales Surge at F1 Austin!

New Heights in Trackside Fashion Well, it looks like Pacsun's got a knack for making the Austin F1 scene as thrilling as the race itself, weaving fashion into the high-speed atmosphere. This year's Formula 1 United States Grand Prix in Austin brought a whopping 19% sales swell in 2026, marking a total sales increase of 177% since their initial 2023 Austin pop-up. Talk...

Everyday Innovation Shines at Canton Fair 2026

Subtle Brilliance in Daily Design You could be swimming in breakthrough tech and miss the real gems — like those sly innovators at this year's Canton Fair. They're overhauling the basics, making ordinary stuff extraordinary with a flick of the wrist. It’s not always the big flashy gadgets that steal the show; sometimes it’s the stealthy little tweaks. Knife...

STARMUS VIII: Bridging Science, Music, and Society

A Constellation of Luminaries at STARMUS You think you've seen it all on this spinning rock, and then something like STARMUS VIII comes around to shake up your perspective. From the Canary Islands, the world just got a little more interesting. We're talking a line-up that could humble the stars themselves—scientific pioneers, musical legends, and cultural icons all...

Bank of America Faces Class-Action Suit in Court

Mixed Bag for Bank of America Investors If you thought you could just park your cash in big banks and slumber through the financial year, think again. Bank of America (NYSE: BAC) has found itself in hot water with a securities fraud class-action suit looming over what some are calling a pretty nasty oversight in compliance. A 4.76% stock drop was a bitter sip for those...

Sands China's Latest Move: A Bond Offering Twist

Breaking Down Sands China's Bond Maneuver Today, we found out that Sands China is teeing up a fresh round of senior unsecured notes. Now, if that doesn't get your ticker flickin', maybe you're too used to market snoozefests. The folks at the helm of Sands China, a subsidiary under the mighty Las Vegas Sands Corp. (NYSE: LVS), are rolling out these USD-denominated notes...

Landis+Gyr's Big Contract Victory: A Game Changer?

Diving into Landis+Gyr's Major Utility Win When news hits about a deal secured by Landis+Gyr Group AG, it rings a few bells across the utility landscape. These folks have brewed up a storm with a fresh contract that slots into their rapidly expanding portfolio of grid-savvy products. So, what’s the fuss about this latest agreement? A Groundbreaking Contract Now, this...

3TREES Debuts Green Coatings to East African Market

3TREES Rocks East Africa's Construction Scene Nairobi's got a spark this week, and it's radiating straight from 3TREES' corner at the Big 5 Construct Kenya. With the Sarit Expo Centre buzzing from October 21, 2026, this Chinese company didn't just show up—they made one hell of an entrance. Presenting eco-friendly coating solutions, they pushed the 'Create Healthy Life'...